The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo.
Among the Ebola viruses most species cause severe hemorrhagic fever in humans; however, Reston ebolavirus (REBOV) has not been associated with human disease despite numerous documented infections. While the molecular basis for this difference remains unclear, in vitro evidence has suggested a role f...
Main Authors: | Allison Groseth, Andrea Marzi, Thomas Hoenen, Astrid Herwig, Don Gardner, Stephan Becker, Hideki Ebihara, Heinz Feldmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS Pathogens |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22876185/pdf/?tool=EBI |
Similar Items
-
Ebola Virus Glycoprotein Domains Associated with Protective Efficacy
by: Bharti Bhatia, et al.
Published: (2021-06-01) -
Ebola virus VP24 interacts with NP to facilitate nucleocapsid assembly and genome packaging
by: Logan Banadyga, et al.
Published: (2017-08-01) -
Molecular determinants of Ebola virus virulence in mice.
by: Hideki Ebihara, et al.
Published: (2006-07-01) -
An upstream open reading frame modulates ebola virus polymerase translation and virus replication.
by: Reed S Shabman, et al.
Published: (2013-01-01) -
Cathepsin B & L are not required for ebola virus replication.
by: Andrea Marzi, et al.
Published: (2012-01-01)